Opicinumab
Opicinumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Opicinumab is under investigation in clinical trial NCT02641041 (Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants).
| Trade Name | Opicinumab |
| Generic | Opicinumab |
| Opicinumab Other Names | Opicinumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Opicinumab
